| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |